Oxybenzone

Oxybenzone

SCHEMBL7191990

COc1ccc(C(=O)c2ccccc2)c(O)c1.O=C(c1ccccc1)c1ccccc1

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.97
LMNA P02545 6/20 0.97
ALDH1A1 P00352 5/20 0.97
MAPK1 P28482 3/20 0.97
HTT P42858 3/20 0.97
CYP1A2 P05177 2/20 0.97
PGR P06401 2/20 0.97
SLC6A2 P23975 2/20 0.97
CYP2C19 P33261 2/20 0.97
CYP2D6 P10635 1/20 0.97
PDE4A P27815 1/20 0.97
HRH1 P35367 1/20 0.97
SLC6A3 Q01959 1/20 0.97
PDE4D Q08499 1/20 0.97
RAB9A P51151 5/20 0.72
NPC1 O15118 5/20 0.72
CYP3A4 P08684 3/20 0.71
ALOX15 P16050 2/20 0.71
ADORA3 P0DMS8 1/20 0.71
AR P10275 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxybenzone SCHEMBL29355332 0.98 HPGD (1.00) HPGDLMNAALDH1A1MAPK1HTT
Oxybenzone SCHEMBL15551 0.98 HPGD (1.00) HPGDLMNAALDH1A1MAPK1HTT
Oxybenzone SCHEMBL5161586 0.98 HPGD (1.00) HPGDLMNAALDH1A1MAPK1HTT
Oxybenzone SCHEMBL419361 0.98 HPGD (1.00) HPGDLMNAALDH1A1MAPK1HTT
Oxybenzone SCHEMBL6674080 0.98 HPGD (1.00) HPGDLMNAALDH1A1MAPK1HTT
Oxybenzone SCHEMBL11414020 0.97 HPGD (0.97) HPGDLMNAALDH1A1MAPK1HTT
Oxybenzone SCHEMBL31403363 0.97 HPGD (0.97) HPGDLMNAALDH1A1MAPK1HTT
Oxybenzone SCHEMBL7243732 0.97 HPGD (0.97) HPGDLMNAALDH1A1MAPK1HTT
Oxybenzone SCHEMBL942845 0.97 HPGD (0.97) HPGDLMNAALDH1A1MAPK1HTT
Oxybenzone SCHEMBL550167 0.97 HPGD (0.97) HPGDLMNAALDH1A1MAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113614122-A Resin modifier 三洋化成工业株式会社 2021-11-05 CN disclosed
CN-103200927-A Oil-in-water type emulsion cosmetic SHISEIDO CO LTD 2013-07-10 CN disclosed
CN-101720218-B Water-in-oil type emulsion composition SHISEDO CO LTD 2012-07-18 CN disclosed
CN-102485196-A Hair dye IKEDA DENSO MATERIAL CO LTD 2012-06-06 CN disclosed
CN-102438581-A Cosmetic preparation SHISEIDO CO LTD 2012-05-02 CN disclosed
CN-102365078-A Solubilized composition SHISEIDO CO LTD 2012-02-29 CN disclosed
CN-102365080-A Solubilized composition SHISEIDO CO LTD 2012-02-29 CN disclosed
CN-102238934-A Oil-in-water cosmetic SHISEIDO CO LTD 2011-11-09 CN disclosed
CN-102046142-A Oil-in-water type topical agent for skin SHISEIDO CO LTD 2011-05-04 CN disclosed
CN-101227888-B Water-in-oil type skin external preparation SHISEIDO CO LTD 2011-01-26 CN disclosed
CN-101720218-A Water-in-oil type emulsion composition SHISEIDO CO LTD 2010-06-02 CN disclosed
CN-100496448-C Oil-in-water emulsion composition SHISEIDO CO LTD (JP) 2009-06-10 CN disclosed
CN-101227888-A Water-in-oil type skin external preparation SHISEIDO CO LTD (JP) 2008-07-23 CN disclosed
CN-100361642-C Cosmetic oil-in-water emulsion preparation SHISEIDO CO LTD (JP) 2008-01-16 CN disclosed
CN-1731970-A Cosmetic oil-in-water emulsion preparation SHISEIDO CO LTD (JP) 2006-02-08 CN disclosed
CN-1636549-A Oil-in-water emulsion composition SHISEIDO CO LTD (JP) 2005-07-13 CN disclosed
US-6582683-B2 Of a hydrophilic polymer emulsion and a hydrophobic polymer emulsion; use to protect skin from irritants, chemical or pathogenic SKINVISIBLE PHARMACEUTICALS, INC. 2003-06-24 US disclosed
CN-1377640-A Skin external preparation ENHUIZHISHUI CO LTD (JP) 2002-11-06 CN disclosed
US-20020051797-A1 DERMAL BARRIER COMPOSITION SKINVISIBLE PHARMACEUTICALS, INC. 2002-05-02 US disclosed
CN-1241133-A Extracellular matrix production promoter SHISEIDO CO LTD (JP) 2000-01-12 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020051797-A1 DERMAL BARRIER COMPOSITION CUTA, DSG1, POLR1C HPGD 1922/4885LMNA 2243/4885ALDH1A1 2807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.